Accuracy of diagnostic codes and algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records: systematic review and meta-analysis
Saka Herran, C.; Bennett, J.; Alkabti, Y.; Fatir, M.; Clyne, B.; McCarthy, C.; Tynan, G.; Dunne, N.; Flood, M.; McCarthy, E.; Moriarty, F.
Show abstract
ObjectiveThis systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) in electronic health records (EHRs). MethodsWe searched MEDLINE, Embase, and CENTRAL databases and included studies that validated case definitions against a reference standard such as rheumatologist-confirmed diagnosis or ACR/EULAR classification criteria. Title/abstract screening, full-text review, data extraction and quality assessment were all completed in duplicate. Results were synthesised narratively and using a bivariate random-effects meta-analysis of sensitivity and specificity. ResultsA total of 35 studies were included. Algorithms varied widely in complexity, ranging from single ICD codes to combinations including disease-modifying antirheumatic drugs (DMARDs), hospitalisation records, and specialist diagnosis. Algorithms combining ICD codes with DMARD prescriptions (pooled sensitivity= 0.79 95% CI 0.61-0.90, specificity= 0.96 95% CI 0.72-1.00, PPV= 0.78 95% CI 0.63-0.88) or requiring an ICD code assigned by a rheumatologist (pooled sensitivity= 0.91 95% CI 0.70-0.98, specificity= 0.94 95% CI 0.49-1.00, PPV= 0.70 95% CI 0.64-0.75) showed the highest accuracy, with balanced sensitivity, specificity, and positive predictive value (PPV). Less restrictive algorithms demonstrated high sensitivity but lower PPV. Substantial heterogeneity was observed across studies, likely due to differences in algorithm structure, data sources, and validation methods. Despite this variability, we used conceptually coherent categories to allow for meaningful synthesis, prioritising clinical interpretability. ConclusionsThese findings support the use of more specific algorithms when diagnostic certainty is essential and highlight the need for further validation of high-performing algorithms across diverse healthcare systems. Significance and Innovations{blacksquare} This is the first comprehensive systematic review to evaluate and synthesize the accuracy of algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records (EHRs), addressing a growing need as real-world data become increasingly central in rheumatology research. {blacksquare}The findings provide critical guidance for researchers and clinicians on the strengths and limitations of commonly used case definitions, helping improve validity of studies using administrative or EHR data. {blacksquare}By categorizing algorithms based on their components and reference standards, this review offers a practical framework for selecting the most appropriate algorithm depending on the study purpose and data source. {blacksquare}The review highlight gaps in validation efforts and emphasizes the need to validate high-performing algorithms across diverse healthcare settings and evolving coding systems, ensuring accurate disease identification in current and future research.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A new indicator to measure discordance between patient reported outcomes and traditional disease activity holds promise to advance care trajectories improve care in patients with early Rheumatoid Arthritis 94%
- Prodromal symptoms of rheumatoid arthritis in a primary care database: variation by ethnicity and socioeconomic status 94%
- Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study 94%
Similar papers in this journal
- Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY 95%
- Gout and coronavirus disease-19 (COVID-19): the risk of diagnosis and death in the UK Biobank 91%
- Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform 91%
Similar papers in this journal
- SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Pediatric Rheumatology Database in Germany 93%
- Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease 92%
- Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care 91%
Similar papers in this journal
- Folic Acid And Methotrexate Use And Their Association With COVID-19 Diagnosis And Mortality: An Analysis From The UK Biobank 92%
- Diagnostic delay of Myositis: protocol for an integrated systematic review 91%
- Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients 91%
Similar papers in this journal
- Risk factors for hospital admission related to COVID-19 in inflammatory rheumatic diseases 93%
- Prevalence of Hospital PCR Confirmed Covid-19 Cases in Patients with Chronic Inflammatory and Autoimmune Rheumatic Diseases 93%
- Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.